Ryo Suzuki

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Oxide Nanoparticles

High Fat Diet Induced

Allergic Rhinitis

Dendritic Cells

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Yuno Suzuki, Lisa Munakata, Daiki Omata, Keiichi Koizumi, Ryo Suzuki
Feasibility study of novel nanoparticles derived from Glycyrrhizae radix as vaccine adjuvant for cancer immunotherapy. Immunotherapy (2023)
Yuno Suzuki, Lisa Munakata, Daiki Omata, Keiichi Koizumi, Ryo Suzuki
Feasibility study of novel nanoparticles derived from Glycyrrhizae radix as vaccine adjuvant for cancer immunotherapy. Immunotherapy 14 (18) (2023)
Yuno Suzuki, Lisa Munakata, Daiki Omata, Keiichi Koizumi, Ryo Suzuki
Feasibility study of novel nanoparticles derived from Glycyrrhizae radix as vaccine adjuvant for cancer immunotherapy. Immunotherapy 14 (18) (2023)
Fumiko Hagiwara, Daiki Omata, Lisa Munakata, Saori Kageyama, Kazuo Maruyama, Nobuki Kudo, Ryo Suzuki
Brain Delivery of Cisplatin Using Microbubbles in Combination with Ultrasound as an Effective Therapy for Glioblastoma. Pharmaceuticals (Basel, Switzerland) 16 (11) (2023)
Yuno Suzuki, Lisa Munakata, Daiki Omata, Keiichi Koizumi, Ryo Suzuki
Feasibility study of novel nanoparticles derived from Glycyrrhizae radix as vaccine adjuvant for cancer immunotherapy. Immunotherapy 14 (18) (2023)